Bullish & Foolish
--
--

Is PMGC Holdings going out of business?

Loading the full analysis
Reading the filings

PMGC Holdings Inc. (ELAB) Fundamentals

A quick summary of the latest filed figures while the full analysis loads.

PMGC Holdings Inc. (ELAB) scores 16 out of 100 on fundamentals, Distressed / Caution, based on SEC filing data.

Quality score 16/100
Rating Distressed / Caution
Sector Biotech/Pharma
Market cap $3.7M
Last close $4.63
Revenue growth (YoY) 13.3%
FCF margin (TTM) -1080.5%
Dividend yield 0.0%

Leading signal: Shares dilution YoY: Reverse split detected; adjusted share change (198.2% YoY) and the capital-structure risk is penalized.

Five questions, kept separate

Survival - Fragile
29+ mo of estimated runway from 2026-06-30, based on $18.1M of cash and short-term investments against $6.4M of annual burn. A disclosed filing event caps this reading; Event Risk carries the detail.
Business quality - Pre-commercial
Operating margins cannot grade a pipeline; Survival and clinical evidence remain the relevant lenses here.
Trajectory - Clinical progress unavailable
Fundamentals can show funding and burn, but not whether the clinical pipeline is advancing.
Valuation - Balanced
75% net-cash backing support a balanced pre-commercial Valuation assessment.
Event risk - Critical event risk
Going-Concern Warning is the decisive filing event; one adverse event family is active. It appears across 2 scanned filings. Favorable events are shown separately and do not offset adverse risk.

What the rules read

  • Shares dilution YoY: Reverse split detected; adjusted share change (198.2% YoY) and the capital-structure risk is penalized.
  • FCF margin: -1080.55%
  • Debt / Equity: 1.39x
  • Filing event risk: Going-Concern Warning (-8 pts)
  • Revenue CAGR (3Y): -8.34%
  • R&D intensity: 63.09%
  • Return on Assets: -21.19%
  • Cash Burn Deceleration: 17.20% QoQ improvement (Path to profitability)
  • Cash Runway (years): 2.85y
  • Debt Maturity Runway: 0% long-term (Near-term refinancing risk)
  • Price / Sales: 6.3x (see Valuation)
  • Price / Earnings: Unprofitable (see Valuation)

Read from filings through 2026-09-02.

Price as of 2026-09-09.

Headline score detail

Source coverage and limitations
--
Reference Links